Abstract:
An apparatus for inspecting a tip shroud includes a frame having top and bottom surfaces. A first stop is connected to the bottom surface to contact a first side surface of the tip shroud, and a second stop is in sliding engagement with the frame to contact a second side surface of the tip shroud. A method for inspecting a tip shroud includes placing an apparatus against the tip shroud, wherein the apparatus has a first stop connected to a frame and a second stop in sliding engagement with the frame. The method further includes engaging the first stop with a first side surface of the tip shroud and sliding the second stop with respect to the frame until the second stop contacts a second side surface of the tip shroud.
Abstract:
A sustained-release pharmaceutical composition which comprises microparticles comprising an active principle, said microparticles being coated with a coating mixture comprising ethyl cellulose and an acrylic resin which is a polymerizate of acrylic and methacrylic ester, having a molecular weight of at least 100,000 and comprising units of formula: ##STR1## wherein: R.sub.1 is hydrogen or methyl,R.sub.2 is methyl or ethyl,R.sub.3 is methyl; andR.sub.4 is --CH.sub.2 --CH.sub.2 N(CH.sub.3).sub.3 Clthe resin containing 5% of trimethylammonium methacrylate chloride units by weight.
Abstract:
A substance dispensing device is disclosed having a body that defines a chamber for receiving a substance capsule. The capsule is operable to dispense substance therefrom and has an outlet through which substance is dispensed. The body has two relatively movable parts that are moved relatively apart from a rest position to condition the device for use. A closure member associated with the movable part obstructs the outlet when the movable parts are in the rest position.
Abstract:
A payment terminal system for a card-based purchase can automatically determine a purchase that is potentially entitled to a tax refund from a billing currency for the payment card indicated in a purchase approval response message in response to payment authorisation request transmitted by the payment terminal system. Tax refund records are allocated. The tax refund records make reference to one or more reference currencies.
Abstract:
The present invention relates to delayed release coated cores comprising an active substance in their core and a polymer coating comprising at least one or more ammonio methacrylate copolymer, characterized in that the core comprises at least a surfactant; to monolithic or multiparticulate pharmaceutical dosage forms comprising such delayed release coated cores and to their method of manufacture.
Abstract:
A transaction terminal system for a card-based purchase communicates with a host system to provide dynamic currency conversion. The transaction terminal system can select one of a number of different rate request messages according to various local factors in order to obtain a currency conversion rate for dynamic currency conversion.
Abstract:
The present invention relates to timed dual release dosage forms of short acting hypnotics or salts thereof adapted to release the short acting hypnotic over a predetermined time period, according to a profile of dissolution characterized in that it comprises two release pulses, the first being immediate (lasting up to 30 minutes) and the second being delayed by a fixed time (this fixed time being between 50 and 200 minutes).
Abstract:
A sustained-release pharmaceutical formulation containing mizolastine, a core formed of a sustained-release table containing mizolastine combined with a fatty matrix and an organic acid, the tablet being coated.
Abstract:
The invention concerns a pharmaceutical composition with gastric residence and controlled release, characterized in that it comprises two or three layers and contains (a) an active principle associated with a excipient modifying its release; (b) a system generating carbon dioxide in a swelling polymer hydrophilic matrix; (a) and (b) capable of being included in a common layer or in separate layers.
Abstract:
A sustained-release pharmaceutical formulation containing mizolastine, a core formed of a sustained-release table containing mizolastine combined with a fatty matrix and an organic acid, the tablet being coated.